Last reviewed · How we verify

NCT03720730: SmartCriseS

SmartCriseS - Smartphone Survey of Suicidal Risk

Status unknown NA Last updated 7 December 2021
What this trial tests

NA trial testing EMA in Personal History of a Recent Suicidal Crisis in 1,044 participants. Status unknown.

Timeline
13 November 2018
Primary endpoint
13 January 2026
13 April 2026

Quick facts

Lead sponsorUniversity Hospital, Montpellier
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment1,044
Start date13 November 2018
Primary completion13 January 2026
Estimated completion13 April 2026
Sites2 locations across France, Spain

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

18 and older, any sex, with Personal History of a Recent Suicidal Crisis or Suicidal Ideation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sleep and appetite disorders as well as social exclusion, have been linked to the emergence of suicidal ideation (SI) and suicide attempts.This study aims to evaluate the relationship between those factors and suicidal ideation and behaviour. To assess those factors an ecological momentary assessment (EMA) desing will be used. EMA will be carried out using 2 applications integrated into the smartphone of participants (Android or iOS), one to make an explicit data collection with questions and another one for the implicit collection of data from mobile sensors. 1044 suicide attempters will be included in three sites and followed for 6 months. Participants will be evaluated at inclusion and at the end of follow-up. The hypothesis is that sleep, appetite and social exclusion factors collected with the smartphone application will be linked to the intensity of death wish, suicidal ideations and suicidal attempts. An auxiliary study will also be led with 300 patients carrying an actimeter for the 30 first days after inclusion. This will help collecting more accurate data on various sleep parameters.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Combining mobile-health (mHealth) and artificial intelligence (AI) methods to avoid suicide attempts: the Smartcrises study protocol.
    Berrouiguet S, Barrigón ML, Castroman JL, Courtet P, et al · · 2019 · cited 41× · PMID 31493783 · DOI 10.1186/s12888-019-2260-y
  2. Multidimensional variability in ecological assessments predicts two clusters of suicidal patients.
    Bonilla-Escribano P, Ramírez D, Baca-García E, Courtet P, et al · · 2023 · cited 7× · PMID 36864070 · DOI 10.1038/s41598-023-30085-1
  3. Impact of age and clinical factors on the feasibility of mobile digital monitoring in people at risk of suicide.
    Conejero I, de Granda-Beltrán AM, Albarracín-García L, Porras-Segovia A, et al · · 2026 · PMID 41990036 · DOI 10.1371/journal.pone.0346772
  4. Association Between Trauma, Impulsivity, and Functioning in Suicide Attempters.
    Escobedo-Aedo PJ, Porras-Segovia A, Barrigón ML, Courtet P, et al · · 2025 · PMID 41009292 · DOI 10.3390/bs15091262

Verify or expand the search:

Other trials of EMA

Trials testing the same drug.

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03720730.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing